Pre- and posttransplant management of solid organ transplant recipients: Risk-adjusted follow-up

Current Problems in Dermatology

Volumn 43, Issue , 2012, Pages 57-70

  Schreve, Bahar Shafaeddin ^a   Anliker, Mark ^b   Arnold, Andreas W ^c   Kempf, Werner ^a   Laffitte, Emmanuel ^d   Lapointe, Anne Karine ^e   Mainetti, Carlo ^f   Pelloni, Francesco ^g   Oberholzer, Patrick ^h   Serra, Andreas ^a   Streit, Markus ⁱ   Hofbauer, Günther F L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f OSPEDALE SAN GIOVANNI   (Switzerland)

^g Studio di Dermatologie   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CAPECITABINE; CYCLOSPORIN A; ETRETIN; FLUOROURACIL; IMIQUIMOD; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOTOSENSITIZING AGENT; VORICONAZOLE;

ACTINIC KERATOSIS; ARTICLE; BOWEN DISEASE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; DERMATOLOGIST; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; MELANOMA; MERKEL CELL TUMOR; METASTASIS; ORGAN TRANSPLANTATION; PHOTOSENSITIVITY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION PROTECTION; RECURRENCE RISK; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN COLOR; SKIN DEFECT; SKIN EXAMINATION; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MASS SCREENING; MELANOMA; ORGAN TRANSPLANTATION; PATIENT EDUCATION AS TOPIC; POSTOPERATIVE CARE; PREOPERATIVE CARE; SARCOMA, KAPOSI; SKIN NEOPLASMS; SUNSCREENING AGENTS;

EID: 84958107036     PISSN: 14215721     EISSN: 16622944     Source Type: Book Series    
DOI: 10.1159/000335152     Document Type: Article

References (70)

1. Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, et al: Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004;30:642-650.
2. Christenson LJ, Geusau A, Ferrandiz C, Brown CD, Ulrich C, Stockfleth E, Berg D, Orengo I, Shaw JC, Carucci JA, Euvrard S, Pacheco T, Stasko T, Otley CC: Specialty clinics for the dermatologic care of solid-organ transplant recipients. Dermatol Surg 2004;30:598-603.
3. Donovan JC, Rosen CF, Shaw JC: Evaluation of sunprotective practices of organ transplant recipients. Am J Transplant 2004;4:1852-1858.
4. Firooz A, Amin-Nejad R, Bouzari N, Nafar M, Firoozan A, Mahdavi-Mazdeh M: Sun protection in Iranian kidney transplant recipients: Knowledge, attitude and practice. J Eur Acad Dermatol Venereol 2007;21:754-757.
5. Lapointe AK, Hofbauer G, Anliker M, Arnold A, Binet I, Hunger R, Kempf W, Pascual M, Pelloni F, Serra A, Laffitte E: Swiss clinical practice guidelines for skin cancer in organ transplant recipients (in French). Rev Med Suisse 2010;6:854-859.
6. Berg D, Otley CC: Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1-17, quiz 18-20.
7. O'Reilly F TC, Pennie ML, Foster JK, Chen SC: Baseline quality of life and anxiety in solid organ transplant recipients: A pilot study. Dermatol Surg 2006;32:1480-1485.
8. Whitmore SE, Morison WL: Prevention of UVBinduced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermatol 1995;131: 1128-1133.
9. Ducloux D, Courivaud C, Bamoulid J, Kazory A, Dumoulin G, Chalopin JM: Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 2008;85:1755-1759.
10. Seukeran DC, Newstead CG, Cunliffe WJ: The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998;138:301-303.
11. Ulrich C, Jurgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E: Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: A 24 months, prospective, case-control study. Br J Dermatol 2009;161(suppl 3):78-84.
12. Norval M, Wulf HC: Does chronic sunscreen use reduce vitamin D production to insufficient levels? Br J Dermatol 2009;161:732-736.
13. Reichrath J NB: Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (SOTRs). Adv Exp Med Biol 2008;624:203-214.
14. Zwald FO, Brown M: Skin cancer in solid organ transplant recipients: Advances in therapy and management. I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:253-261, quiz 262.
15. Hofbauer GF, Anliker M, Arnold A, Binet I, Hunger R, Kempf W, Laffitte E, Lapointe AC, Pascual M, Pelloni F, Serra A: Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly 2009;139:407-415.
16. Hofbauer GF, Attard NR, Harwood CA, McGregor JM, Dziunycz P, Iotzova-Weiss G, Straub G, Meyer R, Kamenisch Y, Berneburg M, French LE, Wuthrich RP, Karran P, Serra AL: Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant 2012;12:218-225.
17. Wu X, Nguyen BC, Dziunycz P, Chang S, Brooks Y, Lefort K, Hofbauer GF, Dotto GP: Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 2010;465:368-372.
18. Zwald FO, Brown M: Skin cancer in solid organ transplant recipients: Advances in therapy and management. II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-279, quiz 280.
19. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA: Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006;86:25-28.
20. de Graaf YG, Kennedy C, Wolterbeek R, Collen AF, Willemze R, Bouwes Bavinck JN: Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: Results of a randomized-controlled trial. J Invest Dermatol 2006;126:569-574.
21. Wennberg AM, Stenquist B, Stockfleth E, Keohane S, Lear JT, Jemec G, Mork C, Christensen E, Kapp A, Solvsten H, Talme T, Berne B, Forschner T: Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: A randomized study. Transplantation 2008;86:423-429.
22. Willey A, Mehta S, Lee PK: Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2009;36:652-658.
23. Ulrich C, Johannsen A, Rowert-Huber J, Ulrich M, Sterry W, Stockfleth E: Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. Eur J Dermatol 2010; 20:482-488.
24. Kovach BT, Stasko T: Use of topical immunomodulators in organ transplant recipients. Dermatol Ther 2005;18:19-27.
25. Perrett CM, McGregor JM, Warwick J, Karran P, Leigh IM, Proby CM, Harwood CA: Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007;156:320-328.
26. Piaserico S, Belloni Fortina A, Rigotti P, Rossi B, Baldan N, Alaibac M, Marchini F: Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007;39: 1847-1850.
27. de Graaf YG, Basdew VR, van Zwan-Kralt N, Willemze R, Bavinck JN: The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodessication. Br J Dermatol 2006;154:493-497.
28. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol 2005; 53:261-266.
29. Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD, Stockfleth E, Tope WD: Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004;30:642-650.
30. Dinehart SM: The treatment of actinic keratoses. J Am Acad Dermatol 2000;42:25-28.
31. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: A prospective study. Lancet Oncol 2008;9:713-720.
32. Veness MJ, Palme CE, Morgan GJ: High-risk cutaneous squamous cell carcinoma of the head and neck: Results from 266 treated patients with metastatic lymph node disease. Cancer 2006;106:2389-2396.
33. O'Reilly Zwald F, Brown M: Skin cancer in solid organ transplant recipients: Advances in therapy and management. II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:263-279.
34. Wagner JD, Evdokimow DZ, Weisberger E, Moore D, Chuang TY, Wenck S, Coleman JJ 3rd: Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004;140:75-79.
35. Ross AS, Schmults CD: Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature. Dermatol Surg 2006;32:1309-1321.
36. Veness MJ, Porceddu S, Palme CE, Morgan GJ: Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007;29:621-631.
37. Tsao H, Atkins MB, Sober AJ: Management of cutaneous melanoma. N Engl J Med 2004;351:998-1012.
38. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519.
39. Dapprich DC, Weenig RH, Rohlinger AL, Weaver AL, Quan KK, Keeling JH, Walsh JS, Otley CC, Christenson LJ: Outcomes of melanoma in recipients of solid organ transplant. J Am Acad Dermatol 2008;59:405-417.
40. Matin RN, Mesher D, Proby CM, McGregor JM, Bouwes Bavinck JN, del Marmol V, Euvrard S, Ferrandiz C, Geusau A, Hackethal M, Ho WL, Hofbauer GF, Imko-Walczuk B, Kanitakis J, Lally A, Lear JT, Lebbe C, Murphy GM, Piaserico S, Seckin D, Stockfleth E, Ulrich C, Wojnarowska FT, Lin HY, Balch C, Harwood CA: Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases. Am J Transplant 2008;8:1891-1900.
41. Dummer R, Hauschild A, Jost L: Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(suppl 2):ii86-ii88.
42. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA: Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006;86:25-28.
43. Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, Zografidis A, Kostakis A: Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 2004;28:595-599.
44. Farge D: Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993;2:339-343.
45. Penn I: Kaposi's sarcoma in organ transplant recipients: Report of 20 cases. Transplantation 1979;27: 8-11.
46. Penn I: Cancers following cyclosporine therapy. Transplant Proc 1987;19:2211-2213.
47. Lebbe C, Legendre C, Frances C: Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 2008;22: 252-261.
48. Schwartz RA, Micali G, Nasca MR, Scuderi L: Kaposi sarcoma: A continuing conundrum. J Am Acad Dermatol 2008;59:179-206, quiz 207-178.
49. Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, Sulkes A, Linn S: Classical Kaposi sarcoma: Prognostic factor analysis of 248 patients. Cancer 2002;95:1982-1987.
50. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV: Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004;77:760-762.
51. Duman S, Toz H, Asci G, Alper S, Ozkahya M, Unal I, Celik A, Ok E, Basci A: Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant 2002; 17:892-896.
52. Kaplan L, Abrams D, Volberding P: Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat Rep 1986;70:1121-1122.
53. Marcelin AG, Roque-Afonso AM, Hurtova M, Dupin N, Tulliez M, Sebagh M, Arkoub ZA, Guettier C, Samuel D, Calvez V, Dussaix E: Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl 2004;10:295-300.
54. Moray G, Basaran O, Yagmurdur MC, Emiroglu R, Bilgin N, Haberal M: Immunosuppressive therapy and Kaposi's sarcoma after kidney transplantation. Transplant Proc 2004;36:168-170.
55. Zavos G, Bokos J, Papaconstantinou J, Boletis J, Gazouli M, Pappas P, Kostakis A: Study of 'de novo' malignancies among Greek renal transplant recipients. Transplant Proc 2003;35:1399-1403.
56. Penn I, First MR: Merkel's cell carcinoma in organ recipients: Report of 41 cases. Transplantation 1999; 68:1717-1721.
57. Otley CC, Berg D, Ulrich C, Stasko T, Murphy GM, Salasche SJ, Christenson LJ, Sengelmann R, Loss GE Jr, Garces J: Reduction of immunosuppression for transplant-associated skin cancer: Expert consensus survey. Br J Dermatol 2006;154:395-400.
58. Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, Claesson K, Stallone G, Russ G, Rostaing L, Kreis H, Burke JT, Brault Y, Scarola JA, Neylan JF: Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006;17:581-589.
59. Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rodler S, Ankersmit J, Zuckermann A, Tschachler E: Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. Int J Dermatol 2008;47:918-925.
60. Mabruk MJ, Toh LK, Murphy M, Leader M, Kay E, Murphy GM: Investigation of the effect of UV irradiation on DNA damage: Comparison between skin cancer patients and normal volunteers. J Cutan Pathol 2009;36:760-765.
61. Laing ME, Dicker P, Murphy GM: Toll-like receptor 4, 7 and 8 polymorphisms have no association with nonmelanoma skin cancer in renal transplant patients. Br J Dermatol 2009;161:715-717.
62. Tuttleton Arron S, Jennings L, Nindl I, Rosl F, Bouwes Bavinck JN, Seckin D, Trakatelli M, Murphy GM: Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 2011;164:1201-1213.
63. Bavinck JN, Tieben LM, Van der Woude FJ, Tegzess AM, Hermans J, ter Schegget J, Vermeer BJ: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-1938.
64. George R, Weightman W, Russ GR, Bannister KM, Mathew TH: Acitretin for chemoprevention of nonmelanoma skin cancers in renal transplant recipients. Australas J Dermatol 2002;43:269-273.
65. Harwood CA, Leedham-Green M, Leigh IM, Proby CM: Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: A 16-year retrospective study. Arch Dermatol 2005;141:456-464.
66. DiGiovanna JJ: Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998;39: S82-S85.
67. McKenna DB, Murphy GM: Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999;140:656-660.
68. Martinez JC, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, Weaver AL: Defining the clinical course of metastatic skin cancer in organ transplant recipients: A multicenter collaborative study. Arch Dermatol 2003;139:301-306.
69. Peramiquel L, Dalmau J, Puig L, Roe E, Fernandez-Figueras MT, Alomar A: Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. J Am Acad Dermatol 2006; 55:S119-S120.
70. Endrizzi BT, Lee PK: Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. Dermatol Surg 2009;35:1567-1572.